{
    "code": "06020975",
    "url": "https:\/\/info.fda.gov.tw\/MLMS\/H0001D.aspx?Type=Lic&LicId=06020975",
    "time": "2024-02-08 21:55:15",
    "許可證字號": "衛署醫器輸字第020975號",
    "註銷狀態": "",
    "註銷日期": "",
    "註銷理由": "",
    "製造許可登錄編號": "QSD4751",
    "有效日期": "114\/04\/15",
    "發證\/登錄日期": "99\/04\/15",
    "許可證\/登錄種類": "醫　器",
    "舊證字號": "",
    "醫療器材級數": "第二等級",
    "第一等級醫療器材原許可證字號": "",
    "第一等級醫療器材新登錄字號": "",
    "通關簽審文件編號": "DHA00602097500",
    "中文品名": "亞培設計師抗環瓜氨酸呔抗體檢驗試劑組",
    "英文品名": "ABBOTT ARCHITECT Anti-CCP",
    "效能": "本產品用於ARCHITECT i系統上，以化學冷光微粒免疫分析法(CMIA)半定量檢測人類血清或血漿中對環瓜氨酸肽(CCP)具有特異性的IgG型自體抗體。",
    "醫器規格": "詳如核定之中文說明書(原110年12月23日標籤、說明書或包裝正本收回作廢)。",
    "劑型": "",
    "包裝": "",
    "儲存溫度": "",
    "有效期間": "",
    "指示藥品審查基準": "",
    "標籤、仿單及包裝加註": "",
    "醫器主類別一": "C免疫學及微生物學裝置",
    "醫器次類別一": "C5775類風濕性因子免疫試驗系統",
    "醫器主類別二": "",
    "醫器次類別二": "",
    "醫器主類別三": "",
    "醫器次類別三": "",
    "藥品分類": "",
    "監視期限": "",
    "主成分略述": "",
    "限制項目": "02輸　入",
    "申請商名稱": "美商亞培股份有限公司台灣分公司",
    "申請商地址": "台北市中山區民生東路三段49號5樓、6樓及51號6樓",
    "主製造廠": [
        {
            "製造廠名稱": "AXIS-SHIELD DIAGNOSTICS LTD.",
            "製造廠廠址": "LUNA PLACE, TECHNOLOGY PARK, DUNDEE, DD2 1XA, UK",
            "製造廠公司地址": "",
            "製造廠國別": "UNITED KINGDOM",
            "製程": ""
        }
    ],
    "次製造廠": [
        {
            "製造廠名稱": "ABBOTT GMBH",
            "製造廠廠址": "MAX-PLANCK-RING 2,65205 WIESBADEN,GERMANY",
            "製造廠公司地址": "",
            "製造廠國別": "GERMANY",
            "製程": ""
        }
    ],
    "藥理治療分類": "",
    "ingredients": [],
    "仿單外盒": [
        {
            "title": "1120717263-020975(1121211核發)-112-12-13.pdf",
            "url": "https:\/\/www.fda.gov.tw\/MLMS\/ShowFile.aspx?LicId=06020975&Seq=023&Type=9"
        },
        {
            "title": "1120717263-020975(1121211核發)-112-12-13.pdf",
            "url": "https:\/\/www.fda.gov.tw\/MLMS\/ShowFile.aspx?LicId=06020975&Seq=024&Type=8"
        }
    ]
}